Previous Terms
of Clearance continue: Prior to the renewal of the 0920-1282
umbrella generic, CDC will consult with the desk officer to develop
a plan for the restructuring of existing instruments, which span
multiple programs. Moving forward, OMB will not approve
multi-program instruments through this generic unless otherwise
agreed upon prior to submission. Gen ICs that are methodologically
complex, that could benefit from public comment, or that could
otherwise necessitate more in-depth review may need to be
resubmitted as new ICRs. GenICs under this generic are approved so
long as the umbrella generic is active; for GenICs requiring data
collection beyond a three-year approval, CDC will need to renew the
umbrella generic. Revisions to GenICs should be submitted as change
requests. CDC should complete an update to the Completion and
Carryover Summary document with each GenIC submission and/or
renewal of the umbrella generic. For programs requesting a change
in data collection frequency (other than annual), CDC will note
this in the GenIC Request Template and provide justification.
Approved consistent with the understanding that CDC will submit
individual collections under this generic clearance to OMB. These
submissions will include the actual study instruments along with a
completed template describing the performance metrics used.
Approved consistent with the understanding that the agency will use
this generic specifically for program improvement and
accountability associated with cooperative agreements and grants.
CDC will send OMB an annual report summarizing the number of hours
used, as well as the nature and results of the activities completed
under this clearance.
Inventory as of this Action
Requested
Previously Approved
06/30/2026
06/30/2026
06/30/2026
11,826
0
11,826
291,147
0
291,147
0
0
0
The purpose of this generic data
collection is to: 1) help CDC programs and their recipients develop
strong performance measurement systems and practices; 2) define and
operationalize priority performance measures; and 3) establish
common data collection and reporting expectations. Data will enable
the accurate, reliable, uniform and timely submission of
recipients' progress. This Non-Substantive Change Request is
submitted to incorporate two additional collections in the TEP
template to respectively monitor progress and completion of the
TEPs through 2024 and 2025. These two collections are found in
Appendix A, sections 2 and 3. The total change in burden over 2
cycles of data collection (2024 and 2025) is 214 hours (107
additional hours of annualized burden). These Change Requests are
submitted to meet 0920-1282 Generic mechanism Terms of
Clearance.
US Code:
42 USC 45 CFR 75.342 Name of Law: Monitoring and reporting
program performance
CDC requests an increase in
burden and responses to accommodate expanded eligibility criteria
for participation in the PMP and anticipated increase in usage of
this generic by CDC/ATSDR programs. In addition, many programs are
funded for multiple years and will need to collect performance data
for the entire period of performance. Note that the change in the
total cost burden appears to be very large. However, the change in
total cost burden is associated with the change in accounting
method. In the past, CDC reported the cost burden for each IC as
the wage-equivalents that appear in Section 12.B of the supporting
statement. Consistent with the rest of HHS, CDC is now reporting
the total from Section 13 in the "burden cost" field for each IC.
Section 13 covers nonwage costs (e.g., equipment). As such, costs
associated with these ICs are now "zero."
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Form 0920-24EV [OADPS] [PMP] A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.
PHIC App B Notification Email.docx
PHIC App A TEP Template.xlsx
PHIG GenIC Request_TEP-rev.pdf
[OADPS] [PMP] A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.